Top
Main

All Outcomes

Feedback
Home
Show Outline
Top   Main   All Outcomes
Home   COVID-19 treatment studies for Alkalinization  COVID-19 treatment studies for Alkalinization  C19 studies: Alkalinization  Alkalinization   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
Loading...
Supplementary Data — Alkalinization for COVID-19: real-time meta analysis of 7 studies
Covid Analysis, March 2023
https://c19early.org/phmeta.html
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Baxter (RCT) 65% 0.35 [0.01-8.27] hosp. 0/37 1/42 OT​1 Improvement, RR [CI] Treatment Control Mody (RCT) 64% 0.36 [0.19-0.68] no improv. 8/30 22/30 Soares (ICU) 76% 0.24 [0.11-0.54] death 6/44 18/32 ICU patients Delić (RCT) 20% 0.80 [0.54-1.18] death 20/42 31/52 Intubated patients El-Badrawy 57% 0.43 [0.09-2.08] death 3/127 3/55 El-Badrawy 39% 0.61 [0.20-1.83] progression 7/127 5/55 El-Badrawy 19% 0.81 [0.68-0.96] no recov. 84/127 45/55 El-Badrawy 73% 0.27 [0.14-0.52] no recov. 127 (n) 55 (n) El-Badrawy 66% 0.34 [0.25-0.47] recov. time 127 (n) 55 (n) El-Badrawy (RCT) 23% 0.77 [0.50-1.18] death 32/272 42/274 El-Badrawy (RCT) 55% 0.45 [0.23-0.87] death 12/247 27/251 El-Badrawy (RCT) 79% 0.21 [0.02-1.76] death 1/125 5/130 El-Badrawy (RCT) 53% 0.47 [0.25-0.88] death 11/63 22/59 El-Badrawy (RCT) -23% 1.23 [0.86-1.75] death 20/25 15/23 El-Badrawy (RCT) 28% 0.72 [0.66-0.80] recov. time 272 (n) 274 (n) El-Badrawy (RCT) 33% 0.67 [0.52-0.85] no recov. 238 (n) 229 (n) Wang (RCT) 39% 0.61 [0.46-0.82] hosp. time 23 (n) 32 (n) Alkalinization COVID-19 outcomes c19early.org/ph Mar 2023 1 OT: comparison with other treatment Favors alkalinization Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit